November 2, 2020
Study finds genetic predictors of cancer treatment side effects
Federico Innocenti, MD, PhD, and colleagues reported they have identified genetic predictors whether a person may be at risk of bevacizumab-induced hypertension.
November 2, 2020
Federico Innocenti, MD, PhD, and colleagues reported they have identified genetic predictors whether a person may be at risk of bevacizumab-induced hypertension.
October 30, 2020
Jenny Ting, PhD, and colleagues published a study showing bacteria mitigated radiation exposure and enhanced the recovery of blood cell production as well as repair of the gastrointestinal tract.
October 19, 2020
Angela Smith, MD, MS, FACS, is one of four recipients of the prize, which is awarded to faculty members who exemplify groundbreaking and innovative research.
October 19, 2020
Thomas Alexander, MD, MPH, and colleagues report on their work to help establish a pediatric hematology-oncology training curriculum in Ethiopia.
October 15, 2020
Lisa A. Carey, MD, FASCO, is the only breast cancer expert in N.C. and the Southeastern U.S. to earn the honor from Expertscape.
October 13, 2020
Adam Goldstein, MD, MPH, Trevor Jolly, MBBS, and Kimberly Shoenbill, MD, PhD, published an editorial in JAMA that states the case for more intensive smoking cessation programs for cancer patients.
October 12, 2020
Zongchao Han, MD, PhD, Barbara Savoldo, MD, PhD, and colleagues report in Nature Cancer they used a combination of CAR-Ts and interleukin (IL)-15 to treat retinoblastoma in a mouse model.
October 9, 2020
Yemi Ogunleye, MD, SM, and colleagues from UNC published findings from a study that analyzed hospitalizations due to lymphedema with the goal to identify factors associated with poor outcomes.
September 28, 2020
UNC Lineberger, Yale Cancer Center and Fox Chase Comprehensive Cancer Center will use the grant to develop better treatments for head and neck squamous cell carcinoma.
September 25, 2020
New research by Chad Pecot, MD, and colleagues shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer.